Steris saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 64 to 71.
How To Invest In Stocks In Both Bull And Bear Markets
This exclusive rating from Investor's Business Daily identifies share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
History reveals that the market's biggest winners typically have an RS Rating of at least 80 in the early stages of their moves. See if Steris can continue to show renewed price strength and clear that threshold.
Steris is trying to complete a flat base with a 236.83 buy point. See if it can clear the breakout price in volume at least 40% above average.
Steris posted 11% earnings growth in the latest quarterly report, while sales growth came in at 6%. Keep an eye out for the company's next round of numbers on or around May 14.
The company holds the No. 7 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical, iRadimed and Masimo are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
